NCT00976443View on ClinicalTrials.gov

Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Obesity
Interventions
DRUG

BTA

BTA 100 or 300 U, endoscopic ultrasound (EUS) guided injections into gastric antrum

DRUG

Placebo (normal saline)

Placebo (normal saline), gastric injections of normal saline

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER